Rolditamig
Rolditamig (TQB2102 Antibody) is a recombinant humanized anti-human epidermal growth factor receptor 2 (HER2) antibody. Rolditamig can be conjugated with an enzyme-cleavable linker and a topoisomerase I inhibitor to form the ADC TQB2102. Rolditamig is applicable to research on solid tumors such as HER2-positive breast cancer.
For research use only. We do not sell to patients.
- CAS No.: 3038136-62-5
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All EGFR Isoforms
More
Biological Activity
immunoglobulin (H-gamma1_L-kappa)_scFvhk-G1(h-CH2-CH3)
Human
|
HER2 |
ERBB2/HER2/CD340
Unconjugated
The product can be reconstituted/diluted with sterile PBS or saline.
-
G1-kappa_scFv-HEAVY-KAPPA-h-CH2-CH3
ELISA, FACS, Functional assay
Chemical Information
-
CAS No. 3038136-62-5
-
SMILES
[Rolditamig]
-
Synonyms
TQB2102 Antibody
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
- Rolditamig
- 3038136-62-5
- TQB2102 Antibody
- ADC Antibodies
- EGFR
- HER2 low metastatic breast cancer
- human epidermal growth factor receptor 2
- HER2 positive gastric cancer
- extracellular domains II
- extracellular domains IV
- HER2 3+ colorectal cancer
- advanced solid tumors
- HER2
- HER2 positive metastatic breast cancer
- Inhibitor
- inhibitor
- inhibit